Drugmakers tap China AI app boom to reach doctors as crackdown upends marketing

The interface of Hydrion, an AI-powered platform from Alibaba Health, is displayed next to the app's logo in this illustration picture taken October 21, 2026. REUTERS/Florence Lo/Illustration

Andrew Silver

12 November, 2026

Alibaba Health jd health OpenEvidence

Printed by Unregistered user on Thu, 12 Nov 2026 00:28:01 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

Drugmakers tap China AI app boom to reach doctors as crackdown upends marketing

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

Chinese drugmaker Ganzhou Hemay puts off HK listing on market conditions

Shanghai-listed drugmaker Biokin files for Hong Kong IPO to fund foray abroad

Read more from Greater China

Alibaba, JD.com, PDD tap AI to keep cautious consumers engaged on Singles Day

Asia Digest: NatureSelect.ai raises over $100m; Aulis Capital closes debut $200m fund

Drugmakers tap China AI app boom to reach doctors as crackdown upends marketing

Register Now to Unlock Premium Content

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

Chinese drugmaker Ganzhou Hemay puts off HK listing on market conditions

Shanghai-listed drugmaker Biokin files for Hong Kong IPO to fund foray abroad

Read more from Greater China

Alibaba, JD.com, PDD tap AI to keep cautious consumers engaged on Singles Day

Asia Digest: NatureSelect.ai raises over $100m; Aulis Capital closes debut $200m fund